Formation Bio Formation Bio (also known as Trialspark) is a technology-driven pharmaceutical company that specializes in clinical trials and drug development. | Dewpoint Therapeutics Dewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. | Stablix Stablix is a biotechnology company that specializes in the field of Targeted Protein Stabilization (TPS). | ![]() Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ||
Founding Date | Founding Date 2020 | Founding Date 2013 | Founding Date 2018 | Founding Date 2021 | Founding Date 2009 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations New York, US HQ | Locations Boston, US HQ Dresden, DE | Locations New York, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 205% decrease | Employees 1775% increase | Employees 1065% decrease | Employees 24 | Employees 407% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 51m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 77m (over 5 years ago) | Latest funding round $ 63m (almost 5 years ago) | Latest funding round $ 100m (over 9 years ago) |
Total funding raised | Total funding raised $ 51m | Total funding raised N/A | Total funding raised $ 137m | Total funding raised $ 63m | Total funding raised $ 220.4m |
Formation Bio (also known as Trialspark) is a technology-driven pharmaceutical company that specializes in clinical trials and drug development.
View companyDewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services.
View companyStablix is a biotechnology company that specializes in the field of Targeted Protein Stabilization (TPS).
View company
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company